P2RY14 has been reported to inhibit UDP-glucose-stimulated chemotaxis of human neutrophils, which prompted further analysis of the relationship between P2RY14 gene expression and neutrophil levels in head and neck cancer (Scrivens and Dickenson, 2006). Here, P2RY14 is linked to head and neck cancer.